Recently, a five-year study was introduced in Kenya about whether or not crypto tokens can be used to improve the health of HIV/AIDS patients lets take a look at it.

An innovative five-year study will be launched in Kenya at the end of the year to investigate whether incentives for crypto tokens can improve the health outcomes of HIV/AIDS patients. On November 1, the blockchain-powered healthcare ecosystem Immunify.Life and Masinde Muliro University of Science and Technology (MMUST) announced that they had received the necessary approvals from the Ethics Committee and the National Commission to begin research.
Together they will conduct a five-year HIV/AIDS study that will begin in Kenya's Kakamega district before the end of 2021 before expanding across the country. MMUST will use Immunify.Life blockchain technology to collect and analyze patient data to improve HIV treatment outcomes. He will assess whether patients achieve better outcomes when stimulated with symbolic rewards for positive health behaviors identified by project sponsors such as NGOs and government agencies. "The program we are testing will provide a symbolic incentive to encourage dropouts to go to the clinic for their treatment."
Also read: Southeast Asian financial institutions switch to Ethereum blockchain
Patients and doctors are provided with Immunify.Life, a native ERC-20 IMM token. He added that they could be offered "a regimen of antibiotics prescribed for tuberculosis" and "encourage HIV patients to return to the clinic regularly for evaluation and treatment". Newing said health workers were also rewarded for positive behavior, such as "correctly completing a counseling protocol, ordering a series of TB tests, or completing medical training".
Each patient using the platform is assigned an irreplaceable tokenized health identifier (NFT) which records critical medical information, such as: This data is then transferred to a digital registry for remote medical monitoring and real-time access to medical data. The study sample size was 600 patients. Half is stimulated by the symbol and the other half serves as control and does not receive any reward with the symbol. Patients will be monitored for six months and will receive active treatment and monthly monitoring.
The study will also monitor the effectiveness of using paperless health monitoring systems in disadvantaged areas. Newing says, “Critical medical computing data can be captured, tagged, and protected in real time; cannot be hacked or altered.” Initially, the platform will use a second-tier Ethereum solution with Polygon, with long-term plans to connect to Cardano.
Also read: Animoca to refund users 265 ETH stolen in a fraud NFT drop Discord scam.
In addition to symbolic gifts from sponsors, patients also benefit financially from the sale of anonymous medical data. Immunify.Life is currently holding private rounds for strategic and institutional investors ahead of its first DEX (IDO) offering, planned for early 2022. “Patients are empowered to take control of their data and share financial rewards. The system is funded by fees charged to organizations that fund and provide health care."
In addition to working on HIV in Kenya, Immunify.Life applies blockchain technology to two other therapeutic areas, COVID-19 and opioid addiction. According to the 2020 UNAIDS report, approximately 1.5 million people in Kenya are living with HIV. Although 70% of these patients are in care, there are problems with tracking, accessing, programming, and data collection. Many people diagnosed with HIV are unable to continue treatment. In some areas, the number of patients dropping out can reach as high as 40%, according to Immunify.Life. This includes pregnant women who can pass the virus to their babies during childbirth.